CELL & GENE ARTICLES, APP NOTES, CASE STUDIES, & WHITE PAPERS

• Driving Digital Excellence In Life Sciences

  The life sciences industry is rapidly evolving through digital transformation and agility. Discover why embracing modern technologies is essential to thrive in today’s competitive landscape.

• Solve ATMP Aseptic Filling Challenges With Gloveless Isolators

  Human intervention is the top contamination risk in ATMP manufacturing. Robotic gloveless isolators address that risk through full automation and real-time monitoring during aseptic filling.

• Supporting Complex Manufacturing For Liquid And Lyophilized Drug Products

  Aseptic fill and finish operations gain efficiency and precision with modular isolator technology, inline weight checks, and lyophilization, which are ideal for mRNA-LNPs and other sensitive modalities.

• Automated Library Prep For Nanopore Human Whole Genome Sequencing

  Gain insight into an automated high‑input workflow that streamlines long‑read whole‑genome library prep, supporting large DNA fragments while reducing reagent use.

• Smart Scaling For Cell And Gene Therapies

  To meet patient demand, advanced therapy manufacturing processes must be commercial ready. CGT sponsors can mitigate risk and protect viability by partnering with a CDMO that prioritizes scalability.

• Mid-Sized Pharma Optimizes Local Affiliate Safety Operations

  Managing local affiliate PV strains any team. See how a mid-sized biopharma standardized ICSR processing across 94 countries, improved compliance tracking, and achieved centralized oversight.

• Seed Train Intensification Using High Cell Density Cryopreservation

  Streamline your upstream bioprocessing with seed train intensification. Discover how high cell density cryopreservation reduces scale-up time, boosts consistency, and enhances manufacturing flexibility.

• Tailored Approach Supports Bladder Cancer Breakthrough

  Discover how a flexible operational strategy and expert site management help bladder cancer programs overcome complex logistical hurdles and achieve critical regulatory milestones.

• Resilience, Risk, And Relationships: CDMO Live Europe 2026 Report

  Senior pharma leaders from Pfizer, Bayer, BioNTech and others debunk dual sourcing myths and reveal what separates strategic CDMO partnerships from transactional ones.

• Scaling Success: A Blueprint For Flexible Biometrics Partnerships

  Learn how a micro-FSP model and integrated biometrics team can scale from specialized support to a full-service solution, ensuring agility and consistency as clinical trial needs evolve.